142 related articles for article (PubMed ID: 10327032)
1. Risk of transient hyperammonemic encephalopathy in cancer patients who received continuous infusion of 5-fluorouracil with the complication of dehydration and infection.
Liaw CC; Wang HM; Wang CH; Yang TS; Chen JS; Chang HK; Lin YC; Liaw SJ; Yeh CT
Anticancer Drugs; 1999 Mar; 10(3):275-81. PubMed ID: 10327032
[TBL] [Abstract][Full Text] [Related]
2. Transient hyperammonemia related to chemotherapy with continuous infusion of high-dose 5-fluorouracil.
Liaw CC; Liaw SJ; Wang CH; Chiu MC; Huang JS
Anticancer Drugs; 1993 Jun; 4(3):311-5. PubMed ID: 8358058
[TBL] [Abstract][Full Text] [Related]
3. Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature.
Mitani S; Kadowaki S; Komori A; Sugiyama K; Narita Y; Taniguchi H; Ura T; Ando M; Sato Y; Yamaura H; Inaba Y; Ishihara M; Tanaka T; Tajika M; Muro K
Medicine (Baltimore); 2017 Jun; 96(22):e6874. PubMed ID: 28562536
[TBL] [Abstract][Full Text] [Related]
4. 5-Fluorouracil-induced hyperammonaemic encephalopathy: A French national survey.
Boilève A; Thomas L; Lillo-Le Louët A; Gaboriau L; Chouchana L; Ducreux M; Malka D; Boige V; Hollebecque A; Hillaire-Buys D; Jozwiak M
Eur J Cancer; 2020 Apr; 129():32-40. PubMed ID: 32120273
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil rechallenge after 5-fluorouracil-induced hyperammonemic encephalopathy.
Boilève A; Wicker C; Verret B; Leroy F; Malka D; Jozwiak M; Pontoizeau C; Ottolenghi C; De Lonlay P; Ducreux M; Hollebecque A
Anticancer Drugs; 2019 Mar; 30(3):313-317. PubMed ID: 30531368
[TBL] [Abstract][Full Text] [Related]
6. Acute encephalopathy attributed to 5-FU.
Langer CJ; Hageboutros A; Kloth DD; Roby D; Shaer AH
Pharmacotherapy; 1996; 16(2):311-3. PubMed ID: 8820478
[TBL] [Abstract][Full Text] [Related]
7. Phase I, pharmacokinetic, and bone marrow drug-level studies of tri-monthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers.
Ho YF; Lu WC; Chen RR; Cheng AL; Yeh KH
Anticancer Drugs; 2011 Mar; 22(3):290-8. PubMed ID: 21150775
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors.
Adjei AA; Reid JM; Diasio RB; Sloan JA; Smith DA; Rubin J; Pitot HC; Alberts SR; Goldberg RM; Hanson LJ; Atherton P; Ames MM; Erlichman C
J Clin Oncol; 2002 Mar; 20(6):1683-91. PubMed ID: 11896120
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion.
Grem JL; Quinn M; Ismail AS; Takimoto CH; Lush R; Liewehr DJ; Steinberg SM; Balis FM; Chen AP; Monahan BP; Harold N; Corse W; Pang J; Murphy RF; Allegra CJ; Hamilton JM
Cancer Chemother Pharmacol; 2001; 47(2):117-25. PubMed ID: 11269737
[TBL] [Abstract][Full Text] [Related]
11. Intermediate dose 5-fluorouracil-induced encephalopathy.
Kim YA; Chung HC; Choi HJ; Rha SY; Seong JS; Jeung HC
Jpn J Clin Oncol; 2006 Jan; 36(1):55-9. PubMed ID: 16436463
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292.
Sparano JA; Lipsitz S; Wadler S; Hansen R; Bushunow PW; Kirkwood J; Flynn PJ; Dutcher JP; Benson AB
Am J Clin Oncol; 1996 Dec; 19(6):546-51. PubMed ID: 8931668
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel in combination with fluorouracil for advanced solid tumors.
Burris HA
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):50-2. PubMed ID: 9364544
[TBL] [Abstract][Full Text] [Related]
14. High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy.
Yeh KH; Cheng AL
Br J Cancer; 1997; 75(3):464-5. PubMed ID: 9020500
[No Abstract] [Full Text] [Related]
15. 5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.
Advani PP; Fakih MG
Anticancer Res; 2011 Jan; 31(1):335-8. PubMed ID: 21273620
[TBL] [Abstract][Full Text] [Related]
16. The aggravating factors of hyperammonemia related to 5-fluorouracil infusion--a report of two cases.
Kikuta S; Asakage T; Nakao K; Sugasawa M; Kubota A
Auris Nasus Larynx; 2008 Jun; 35(2):295-9. PubMed ID: 17826933
[TBL] [Abstract][Full Text] [Related]
17. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer.
Hansen RM; Ryan L; Anderson T; Krzywda B; Quebbeman E; Benson A; Haller DG; Tormey DC
J Natl Cancer Inst; 1996 May; 88(10):668-74. PubMed ID: 8627643
[TBL] [Abstract][Full Text] [Related]
18. Continuous-infusion 5-fluorouracil and cisplatin for advanced/recurrent transitional cell cancer of the bladder: a Southwest Oncology Group trial.
Kish JA; Wolf MK; Schellhammer PF; Hussain MH; Einstein AB; Crawford ED
Am J Clin Oncol; 1997 Aug; 20(4):327-30. PubMed ID: 9256883
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of 5-fluorouracil concentration in peripheral blood and side effects in continuous hepatic arterial infusion chemotherapy for patients with unresectable liver cancer].
Fujii K; Nakashima K; Ohno T; Anai H
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1835-7. PubMed ID: 9382545
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
